Qube Research & Technologies Ltd - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$297
-99.7%
188
-98.4%
0.00%
-100.0%
Q4 2021$87,00011,6650.00%
Other shareholders
ATYR PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 624,000$1,3672.16%
Tikvah Management LLC 1,350,833$2,958,3241.41%
VR Adviser, LLC 1,171,436$2,565,4450.43%
TANG CAPITAL MANAGEMENT LLC 123,430$270,3120.04%
FEDERATED HERMES, INC. 5,231,600$11,457,2040.03%
Alyeska Investment Group, L.P. 1,378,747$3,019,4560.03%
Walleye Capital LLC 750,000$1,642,5000.03%
Tower Research Capital LLC (TRC) 17,443$380.00%
CITIGROUP INC 428,460$938,3270.00%
PFS Partners, LLC 406$8900.00%
View complete list of ATYR PHARMA INC shareholders